X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (37) 37
Publication (7) 7
Conference Proceeding (5) 5
Dissertation (5) 5
Book / eBook (3) 3
Newspaper Article (3) 3
Book Chapter (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
animals (12) 12
mice (11) 11
insulin resistance (10) 10
obesity (10) 10
health aspects (9) 9
humans (9) 9
male (9) 9
physiological aspects (8) 8
diabetes (7) 7
gene expression (6) 6
research (6) 6
homeostasis (5) 5
insulin (5) 5
mice, inbred c57bl (5) 5
adipose tissues (4) 4
adult (4) 4
article (4) 4
dendritic cells (4) 4
endocrinology & metabolism (4) 4
female (4) 4
glucose (4) 4
mice, knockout (4) 4
mice, obese (4) 4
obesity - metabolism (4) 4
physiology (4) 4
rodents (4) 4
vitamin a (4) 4
acetylation (3) 3
adipocytes (3) 3
articles (3) 3
cells, cultured (3) 3
diabetes mellitus, type 2 - metabolism (3) 3
glucose - metabolism (3) 3
matrix metalloproteinase 9 - genetics (3) 3
medicine, research & experimental (3) 3
metabolic syndrome (3) 3
middle aged (3) 3
nutrition & dietetics (3) 3
proteins (3) 3
rats (3) 3
type 2 diabetes (3) 3
weight-loss (3) 3
adipose tissue (2) 2
adipose tissue, brown - metabolism (2) 2
adipose tissue, white - metabolism (2) 2
antigen presenting cells (2) 2
bariatric surgery (2) 2
biochemistry & molecular biology (2) 2
bone-marrow (2) 2
care and treatment (2) 2
cell adhesion - drug effects (2) 2
cell biology (2) 2
comparative analysis (2) 2
diabetes mellitus (2) 2
dideoxynucleosides - therapeutic use (2) 2
diet, high-fat (2) 2
diet-induced obesity (2) 2
disease (2) 2
drug therapy (2) 2
extracellular-matrix (2) 2
gelatinase-b (2) 2
gene deletion (2) 2
genetic aspects (2) 2
glucose clamp technique (2) 2
glucose tolerance test (2) 2
histones - metabolism (2) 2
hiv infections - drug therapy (2) 2
hiv-1 - genetics (2) 2
immunology (2) 2
inflammation (2) 2
insulin resistance - physiology (2) 2
insulin sensitivity (2) 2
insulin-resistance (2) 2
lamivudine - therapeutic use (2) 2
lopinavir (2) 2
matrix metalloproteinase 9 - metabolism (2) 2
metabolism (2) 2
molecular sequence data (2) 2
mouse (2) 2
multidisciplinary sciences (2) 2
obesity - genetics (2) 2
obesity - pathology (2) 2
observations (2) 2
p300-cbp transcription factors - metabolism (2) 2
pathway (2) 2
patients (2) 2
phosphorylation (2) 2
ppar-gamma (2) 2
properties (2) 2
public health (2) 2
pyrimidinones - therapeutic use (2) 2
receptors (2) 2
receptors, retinoic acid - antagonists & inhibitors (2) 2
resistance (2) 2
retinoic acid receptor alpha (2) 2
ritonavir - therapeutic use (2) 2
sensitivity (2) 2
society-usa panel (2) 2
t-lymphocytes, regulatory - immunology (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 2015, Volume 21, Issue 2, pp. 159 - 165
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 10/2019, Volume 9, Issue 1, pp. 1 - 10
Journal Article
Nature Medicine, ISSN 1078-8956, 2014, Volume 20, Issue 8, pp. 942 - 947
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 06/2013, Volume 304, Issue 11, pp. E1175 - E1187
Journal Article
Journal Article
Nature, ISSN 0028-0836, 09/2014, Volume 513, Issue 7518, pp. 436 - 439
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 07/2009, Volume 23, Issue 12, pp. 1547 - 1556
Background: Abacavir sulfate/lamivudine (ABC/3TC) and tenofovir DF/emtricitabine (TDF/FTC) are widely used nucleoside reverse transcriptase inhibitors for... 
Emtricitabine | Tenofovir | Ritonavir | Lopinavir | Abacavir | Lamivudine | Antiretroviral therapy | emtricitabine | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | tenofovir | antiretroviral therapy | NAIVE HIV-1-INFECTED PATIENTS | IMMUNOLOGY | REVERSE-TRANSCRIPTASE INHIBITORS | VIROLOGY | lopinavir | ritonavir | RENAL-FAILURE | abacavir | SOCIETY-USA PANEL | INFECTED PATIENTS | 2008 RECOMMENDATIONS | FANCONI-SYNDROME | lamivudine | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | Lamivudine - adverse effects | HIV Infections - immunology | Deoxycytidine - therapeutic use | Adenine - adverse effects | Ritonavir - adverse effects | Adenine - therapeutic use | HIV-1 - isolation & purification | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Dideoxynucleosides - therapeutic use | Antiretroviral Therapy, Highly Active - methods | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | HIV-1 - genetics | HIV Infections - drug therapy | Cardiovascular Diseases - chemically induced | Deoxycytidine - analogs & derivatives | Index Medicus | AIDS/HIV
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9534, pp. 476 - 482
Lopinavir-ritonavir is a preferred protease inhibitor co-formulation for initial HIV-1 treatment. Fosamprenavir-ritonavir has shown similar efficacy and safety... 
MEDICINE, GENERAL & INTERNAL | THERAPY | NAIVE PATIENTS | RECOMMENDATIONS | EFAVIRENZ | TENOFOVIR DF | RESISTANCE | AIDS | SOCIETY-USA PANEL | LOPINAVIR/RITONAVIR | NELFINAVIR | Dideoxynucleosides - administration & dosage | Organophosphates - administration & dosage | Lamivudine - administration & dosage | Ritonavir - administration & dosage | HIV-1 - drug effects | Humans | Lopinavir | Pyrimidinones - therapeutic use | Organophosphates - therapeutic use | Carbamates - administration & dosage | HIV Protease Inhibitors - administration & dosage | HIV-1 - genetics | Reverse Transcriptase Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Sulfonamides - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | HIV Infections - drug therapy | Dideoxynucleosides - therapeutic use | Pyrimidinones - administration & dosage | Reverse Transcriptase Inhibitors - therapeutic use | Carbamates - therapeutic use | Drug Therapy, Combination | Sulfonamides - administration & dosage | Dosage and administration | Protease inhibitors | Comparative analysis | Drug therapy | HIV infection | Antiviral agents | Research | Drug therapy, Combination | Health aspects | Anti-HIV agents | Antiretroviral drugs | Human immunodeficiency virus--HIV | Samples | Clinical trials | Comparative studies | Clinical medicine | Disease control
Journal Article